Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Gov. Lamont speaks out on airport, workers council

State ‘desperately needs good regional airport in south central Connecticut,’ Gov. Ned Lamont says. Will it be Tweed New Haven or Sikorsky Memorial? … more...

| By Kelley Gipson

Where should I invest to get into healthcare?

Cities and state looking to remake their economies by attracting venture capital and business innovators to their markets would be wise to consider healthcare. Within...

| By Kelley Gipson

Some biotech leaders are on a personal mission

In recent years, the New Haven region has seen an explosion of new biotech firms making strides on treatments for devastating diseases, from various cancers...

| By Kelley Gipson

Grant to UConn’s Mellone re centromere’s role

University of Connecticut associate professor of molecular and cell biology Barbara Mellone has received a $2.6 million Maximizing Investigators Research Award from the National Institutes...

| By Kelley Gipson

New Yale science building expands possibilities

Yale researchers and students are poised to benefit from cutting-edge new facilities at the Yale Science Building (YSB). Located in the footprint of the former...

| By Kelley Gipson

The race for research and lab space in New Haven

The New Haven area has become a hub for thriving and growing young bioscience companies like Arvinas and Cybrexa Therapeutics, which are working to develop...

| By Kelley Gipson

InveniAI® adds new products to its AI discovery suite

InveniAI® Corporation has expanded its flagship AI- and ML-driven innovation monitoring platform, AlphaMeld™ to include products for pharmaceutical drug discovery and development stakeholders. TargetMeld™ and...

| By Kelley Gipson

Rallybio expands leadership team

Rallybio reports that it has added Amanda Hayward, PhD and Lisa Sinclair to the Rallybio team. Dr. Hayward will focus on further building Rallybio’s portfolio and Ms....

| By Kelley Gipson

IsoPlexis gets grant from National Cancer Institute

IsoPlexis has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research Development Center for the advancement of intracellular proteomic pathway...

| By Kelley Gipson

Advancing health at The Jackson Laboratory

Over the course of 40 days on the International Space Station (ISS), researchers will determine the effect of microgravity on JAX’s Mighty Mice — genetically...